Psychiatric syndromes related to antiepileptic drugs

Epilepsia

Volumn 40, Issue SUPPL. 10, 1999, Pages s65-s70

  Schmitz, Bettina ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Antiepileptic drugs; Epilepsy; Forced normalization; Positive psychotropic effects; Side effects

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; ETHOSUXIMIDE; FELBAMATE; GABAPENTIN; LAMOTRIGINE; PHENYTOIN; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ANTICONVULSANT ACTIVITY; ANTICONVULSANT THERAPY; BEHAVIOR DISORDER; BRAIN DISEASE; CONFERENCE PAPER; DEPRESSION; DISEASE PREDISPOSITION; DRUG SAFETY; GENETIC SUSCEPTIBILITY; HUMAN; PRIORITY JOURNAL; PSYCHOSIS; RISK ASSESSMENT;

EID: 0032779116     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1999.tb00887.x     Document Type: Conference Paper

References (45)

1. Schmitz B., Wolf P. Psychosis with epilepsy: frequency and risk factors. J Epilepsy 1995;8:295-305.
2. Schmitz B, Robertson M, Trimble MR. Schizophrenia and depression: the role of antiepileptic drugs. Pharmacopsychiatry 1995;28: 213.
3. Sommer W. Postepileptisches Irresein. Arch Psychiatr Nervenkr 1881;11:549-612.
4. Ketter TA, Nalow BA, Flamini R, White SR, Post RM, Theodore WH. Anticonvulsant withdrawal-emergent psychopathology. Neurology 1994;44:55-61.
5. Hoffmann H. Beobachtungen und Erfahrungen über Seelenstörungen und Epilepsie. Frankfurt/Main: Rütten, 1859.
6. Fischer F. Zur Lehre des epileptischen Irresein. Arch Pcychiat Nervenkr 1884;15:741-76.
7. Christinger M. Über der Einfluss einer wirksamen Epilepsiebehandlung auf die Psyche der Epileptiker. Epilepsia 1914/15;5:223-42.
8. Robertson MM, Trimble MR, Townsend HRA. Phenomenology of depression in epilepsy. Epilepsia 1987;28:364-72.
9. Brent DA. Overrepresentation of epileptics in a consecutive series of suicide attempters seen at a children's hospital, 1978-1983. J Am Acad Child Psychiatry 1986;25:242-6.
10. Brent DA, Crumrine PK, Varma RR, Allan M, Allman C. Phenobarbital treatment and major depressive disorder in children with epilepsy. Pediatrics 1987;80:909-17.
11. Dalby MA. Behavioral effects of carbamazepine. In: Penry JK, Daly DD, eds. Complex partial seizures and their treatment. Advances in Neurology. Vol. 11, New York: Raven Press, 1975:331-43.
12. Drake ME, Peruzzi WT. Manic state with carbamazepine therapy of seizures. J Natl Med Assoc 1986;78:1105-7.
13. Trimble MR. Neuropsychiatric consequences of pharmacotherapy. In: Engel J, Pedley TA, eds. Epilepsy. A comprehensive textbook. Philadelphia, New York: Lippincott-Raven, 1997:2161-70.
14. Sackellares JC, Lee SI, Dreifuss FE. Stupor following administration of valproic acid to patients receiving other convulsant drugs. Epilepsia 1979;20:697-703.
15. Zaret BS, Cohen RA. Reversible valproic acid-induced dementia: a case report. Epilepsia 1986;27:234-40.
16. Duarte J, Macias S, Coria F, Fernandez E, Clavcria LE. Valproate induced coma: a case report and literature review. Ann Pharmacother 1993;27:582-3.
17. Schöndienst M, Wolf P. Zur Möglichkeit neurotoxischer Spätwirkungen von Valproinsäure. In: Krämer G, Laub M, eds. Valproinsäure. Berlin, Heidelberg, New York: Springer, 1992: 259-65.
18. Trimble MR, Reynolds EH. Anticonvulsant drugs and mental symptoms: a review. Psychol Med 1976;6:169-78.
19. Schmidt D. Epilepsien und epileptische Anfälle. Stuttgart: Thieme, 1992.
20. Wolf P, Inoue Z, Röder-Wanner UU, Tsai JJ. Psychiatric complications of absence therapy and their relation to alteration of sleep. Epilepsia 1984;25:56-9.
21. McDanal CE, Bolman WM, Delayed idiosyncratic psychosis with diphenylhydantoin JAMA 1975;231:1063.
22. Schmitz B, Trimble MR. PIP-syndrome in temporal lobe epilepsy. Epilepsy Res 1995;22:215-20.
23. Trimble MR. Forced normalisation and the role of anticonvulsants. In: Trimble MR, Schmitz B. eds. Forced normalisation. Petersfield, UK: Wrightson Biomedical Publishing, 1998:169-78.
24. Sander JWAS, Hart ZM, Trimble MR, Shorvon SD. Vigabatrin and psychosis. J Neurol Neurosurg Psychiatry 1991;54:435-9.
25. Sälke-Kellermann A, Baier H, Rambeck B, Boenigk HE, Wolf P. Acute encephalopathy with vigabatrin. Lancet 1993;342:185.
26. Rogers D, Bird J, Eames P. Complex partial status after starting vigabatrin. Seizure 1993;2:155-6.
27. Naumann M, Supprian T, Kornhuber J, Lange KW, Reiners K. Bipolar affective psychosis after vigabatrin. Lancet 1994;343: 606-7.
28. Sastre-Garau P, Thomas P, Beaussart M, Goudemand M. Accès maniaque consècutif à une association vigabatrin-clomipramine. Lencephale 1993;19:351-2.
29. Ferrie CD, Robinson RO, Panaziotopoulos CP. Psychotic and severe behavioural reactions with vigabatrin: a review. Acta Neurol Scand 1996;93:1-8.
30. Dulac O, Chiron D, Cusmai R, Pajot N, Beaumont D, Mondragon S. Vigabatrin in childhood epilepsy. J Child Neurol 1991; 6(suppl 2):30-7.
31. Thomas L, Trimble MR, Schmitz B, Ring H. Vigabatrin and behaviour disorders: a retrospective Survey. Epilepsy Res 1996;25: 21-7.
32. Brodie M. Monotherapy with vigabatrin (Abstract). Presented at the Second European Congress of Epileplology, Update on Sabril, The Hague, 1996.
33. Smith D, Baker G, Davies G, Dewey M, Chadwick D. Outcomes of add on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34:312-22.
34. Binnie DB. Lamotrigine. In: Engel J, Pedley TA, eds. Epilepsy. A comprehensive textbook. Philadelphia, New York: Lippincott-Raven, 1997:1531-40.
35. Fitton A, Goa KL. Lamotrigine. Drugs 1995;50:691-713.
36. McConnell H, Snyder PJ, Duffy JD, et al. Neuropsychiatric side effects related to treatment with felbamate. J Neuropsychiatry Clin Neurosci 1996;8:341-6.
37. Lee DO, Steingard RJ, Cesena M, Helmers SL, Riviello JJ, Mikati MA. Behavioral side effects of gabapentin in children. Epilepsia 1996;37:87-90.
38. Wolf SM, Shinnar S, Kang H, Balaban Gil K, Moshé SL. Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia 1996;36:1203-5.
39. Tallian KB, Nahata MC, Lo W, Tsao CZ. Gabapentin associated with aggressive behavior in pediatric patients with seizures. Epilepsia 1996;37:501-2.
40. Schapel G, Chadwick D. Tiagabine and non-convulsive status epilepticus. Seizure 1996;5:153-6.
41. Leppik E. Tiagabine: the safely landscape. Epilepsia 1995;36 (suppl 6):10-3.
42. Schmitz B. Psychiatrische Symptome bei Epilepsie - welchen Effekt haben Antiepileptika? Oral presentation. Novo Nordisk Satelliten Symposium, German League Against Epilepsy, Handout: Tiagabin: Ein weiterer Schritt in der Kunst zu helfen, 1996, 24-27.
43. Janssen-Cilag. Topamax. Product monograph, 1996.
44. Luef G, Bauer G. Topiramate in drug-resistant partial and generalized epilepsies [Abstract]. Epilepsia 1996;37(suppl 4):69.
45. Kasumakar V, Yatham LN. An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 1997;19:145-8.